376 related articles for article (PubMed ID: 31911242)
1. Identification and characterization of fragment binding sites for allosteric ligand design using the site identification by ligand competitive saturation hotspots approach (SILCS-Hotspots).
MacKerell AD; Jo S; Lakkaraju SK; Lind C; Yu W
Biochim Biophys Acta Gen Subj; 2020 Apr; 1864(4):129519. PubMed ID: 31911242
[TBL] [Abstract][Full Text] [Related]
2. Reproducing crystal binding modes of ligand functional groups using Site-Identification by Ligand Competitive Saturation (SILCS) simulations.
Raman EP; Yu W; Guvench O; Mackerell AD
J Chem Inf Model; 2011 Apr; 51(4):877-96. PubMed ID: 21456594
[TBL] [Abstract][Full Text] [Related]
3. Site Identification by Ligand Competitive Saturation (SILCS) simulations for fragment-based drug design.
Faller CE; Raman EP; MacKerell AD; Guvench O
Methods Mol Biol; 2015; 1289():75-87. PubMed ID: 25709034
[TBL] [Abstract][Full Text] [Related]
4. Inclusion of multiple fragment types in the site identification by ligand competitive saturation (SILCS) approach.
Raman EP; Yu W; Lakkaraju SK; MacKerell AD
J Chem Inf Model; 2013 Dec; 53(12):3384-98. PubMed ID: 24245913
[TBL] [Abstract][Full Text] [Related]
5. Assessing hERG1 Blockade from Bayesian Machine-Learning-Optimized Site Identification by Ligand Competitive Saturation Simulations.
Mousaei M; Kudaibergenova M; MacKerell AD; Noskov S
J Chem Inf Model; 2020 Dec; 60(12):6489-6501. PubMed ID: 33196188
[TBL] [Abstract][Full Text] [Related]
6. Application of Mixed-Solvent Molecular Dynamics Simulations for Prediction of Allosteric Sites on G Protein-Coupled Receptors.
Chan WKB; Carlson HA; Traynor JR
Mol Pharmacol; 2023 May; 103(5):274-285. PubMed ID: 36868791
[TBL] [Abstract][Full Text] [Related]
7. Mapping functional group free energy patterns at protein occluded sites: nuclear receptors and G-protein coupled receptors.
Lakkaraju SK; Yu W; Raman EP; Hershfeld AV; Fang L; Deshpande DA; MacKerell AD
J Chem Inf Model; 2015 Mar; 55(3):700-8. PubMed ID: 25692383
[TBL] [Abstract][Full Text] [Related]
8. Identifying and Assessing Putative Allosteric Sites and Modulators for CXCR4 Predicted through Network Modeling and Site Identification by Ligand Competitive Saturation.
Inan T; Flinko R; Lewis GK; MacKerell AD; Kurkcuoglu O
J Phys Chem B; 2024 May; 128(21):5157-5174. PubMed ID: 38647430
[TBL] [Abstract][Full Text] [Related]
9. Optimization and Evaluation of Site-Identification by Ligand Competitive Saturation (SILCS) as a Tool for Target-Based Ligand Optimization.
Ustach VD; Lakkaraju SK; Jo S; Yu W; Jiang W; MacKerell AD
J Chem Inf Model; 2019 Jun; 59(6):3018-3035. PubMed ID: 31034213
[TBL] [Abstract][Full Text] [Related]
10. SILCS-RNA: Toward a Structure-Based Drug Design Approach for Targeting RNAs with Small Molecules.
Kognole AA; Hazel A; MacKerell AD
J Chem Theory Comput; 2022 Sep; 18(9):5672-5691. PubMed ID: 35913731
[TBL] [Abstract][Full Text] [Related]
11. Computational fragment-based binding site identification by ligand competitive saturation.
Guvench O; MacKerell AD
PLoS Comput Biol; 2009 Jul; 5(7):e1000435. PubMed ID: 19593374
[TBL] [Abstract][Full Text] [Related]
12. Pharmacophore modeling using site-identification by ligand competitive saturation (SILCS) with multiple probe molecules.
Yu W; Lakkaraju SK; Raman EP; Fang L; MacKerell AD
J Chem Inf Model; 2015 Feb; 55(2):407-20. PubMed ID: 25622696
[TBL] [Abstract][Full Text] [Related]
13. Estimation of relative free energies of binding using pre-computed ensembles based on the single-step free energy perturbation and the site-identification by Ligand competitive saturation approaches.
Raman EP; Lakkaraju SK; Denny RA; MacKerell AD
J Comput Chem; 2017 Jun; 38(15):1238-1251. PubMed ID: 27782307
[TBL] [Abstract][Full Text] [Related]
14. Computational Characterization of Antibody-Excipient Interactions for Rational Excipient Selection Using the Site Identification by Ligand Competitive Saturation-Biologics Approach.
Jo S; Xu A; Curtis JE; Somani S; MacKerell AD
Mol Pharm; 2020 Nov; 17(11):4323-4333. PubMed ID: 32965126
[TBL] [Abstract][Full Text] [Related]
15. Exploring protein-protein interactions using the site-identification by ligand competitive saturation methodology.
Yu W; Jo S; Lakkaraju SK; Weber DJ; MacKerell AD
Proteins; 2019 Apr; 87(4):289-301. PubMed ID: 30582220
[TBL] [Abstract][Full Text] [Related]
16. Site-Identification by Ligand Competitive Saturation (SILCS) assisted pharmacophore modeling.
Yu W; Lakkaraju SK; Raman EP; MacKerell AD
J Comput Aided Mol Des; 2014 May; 28(5):491-507. PubMed ID: 24610239
[TBL] [Abstract][Full Text] [Related]
17. Moving Beyond Active-Site Detection: MixMD Applied to Allosteric Systems.
Ghanakota P; Carlson HA
J Phys Chem B; 2016 Aug; 120(33):8685-95. PubMed ID: 27258368
[TBL] [Abstract][Full Text] [Related]
18. Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist.
Pandey P; Roy KK; Doerksen RJ
J Biomol Struct Dyn; 2020 Jan; 38(1):32-47. PubMed ID: 30652534
[TBL] [Abstract][Full Text] [Related]
19. Application of Site-Identification by Ligand Competitive Saturation in Computer-Aided Drug Design.
Goel H; Hazel A; Yu W; Jo S; MacKerell AD
New J Chem; 2022 Jan; 46(3):919-932. PubMed ID: 35210743
[TBL] [Abstract][Full Text] [Related]
20. Accelerated structure-based design of chemically diverse allosteric modulators of a muscarinic G protein-coupled receptor.
Miao Y; Goldfeld DA; Moo EV; Sexton PM; Christopoulos A; McCammon JA; Valant C
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5675-84. PubMed ID: 27601651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
